Affordable Access

New smallpox vaccines for an ancient scourge.

Authors
Type
Published Article
Journal
Missouri medicine
Publication Date
Volume
111
Issue
4
Pages
332–336
Identifiers
PMID: 25211864
Source
Medline
License
Unknown

Abstract

The potential use of variola virus, a Class A agent of bioterrorism, remains a concern. In an effort to prepare for a possible smallpox outbreak due to an intentional release of variola, the U.S. government and industry have been evaluating vaccines stored in the National Strategic Stockpile including cell culture grown ACAM2000 and modified vaccinia Ankara, IMVAMUNE, in clinical studies. This paper discusses smallpox vaccines studies conducted at the Saint Louis University Center for Vaccine Development.

Statistics

Seen <100 times